Literature DB >> 17492683

The quality of surgical pathology care for men undergoing radical prostatectomy in the U.S.

David C Miller1, Benjamin A Spencer, Rajal B Shah, Jamie Ritchey, Andrew K Stewart, E Greer Gay, Rodney L Dunn, John T Wei, Mark S Litwin.   

Abstract

BACKGROUND: The authors assessed adherence with the College of American Pathologists (CAP) radical prostatectomy (RP) practice protocol in a national sample of men who underwent RP for early-stage prostate cancer.
METHODS: Using the National Cancer Data Base, the authors identified a nationally representative sample of 1240 men (unweighted) who underwent RP. For each patient, local cancer registrars performed an explicit medical record review to assess patient-level compliance with surgical pathology report documentation of 7 morphologic criteria (ie, quality indicators). Applying the CAP prognostic factor classification framework, composite measures and all-or-none measures of quality indicator compliance were calculated for the following analytic categories: 1) a strict subset of CAP category I prognostic factors (3 indicators), 2) a broad subset of CAP category I factors (6 indicators), and 3) the full set of 7 indicators.
RESULTS: Among a weighted sample of 24,420 patients who underwent RP, compliance with documentation of the CAP category I factors varied from 54% (95% confidence interval [95% CI], 50-58%) for pathologic tumor, lymph node, metastases classification (according to the American Joint Committee on Cancer staging system) to 97% (95% CI, 96-99%) for Gleason score. In composite, RP pathology reports contained 83% (95% CI, 81-84%), 85% (95% CI, 84-87%), and 79% (95% CI, 78-80%) of the recommended data elements measured by the strict CAP category I subset, the broad CAP category I subset, and the full set of 7 indicators, respectively. In contrast to the generally higher composite scores, only 52% (95% CI, 48-56%) and 41% (95% CI, 37-45%) of men who underwent RP had complete documentation in their pathology reports for the strict and broad CAP category I subsets, respectively.
CONCLUSIONS: RP surgical pathology reports contained most of the recommended data elements; however, the frequent absence of pathologic stage provides an opportunity for quality improvement. Copyright 2007 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17492683     DOI: 10.1002/cncr.22698

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap.

Authors:  Daniel A Barocas; David F Penson
Journal:  BJU Int       Date:  2010-06-14       Impact factor: 5.588

2.  Urologist practice structure and quality of prostate cancer care.

Authors:  Parth K Modi; Phyllis Yan; Brent K Hollenbeck; Samuel R Kaufman; Tudor Borza; Ted A Skolarus; Florian R Schroeck; Andrew M Ryan; Vahakn B Shahinian; Lindsey A Herrel
Journal:  Urol Pract       Date:  2020-09-01

Review 3.  Understanding variation in the quality of the surgical treatment of prostate cancer.

Authors:  Florian R Schroeck; Bruce L Jacobs; Brent K Hollenbeck
Journal:  Am Soc Clin Oncol Educ Book       Date:  2013

4.  Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.

Authors:  Daniel A Barocas; Vivien Chen; Matthew Cooperberg; Michael Goodman; John J Graff; Sheldon Greenfield; Ann Hamilton; Karen Hoffman; Sherrie Kaplan; Tatsuki Koyama; Alicia Morgans; Lisa E Paddock; Sharon Phillips; Matthew J Resnick; Antoinette Stroup; Xiao-Cheng Wu; David F Penson
Journal:  J Comp Eff Res       Date:  2013-07       Impact factor: 1.744

5.  Health Care Integration and Quality among Men with Prostate Cancer.

Authors:  Lindsey A Herrel; Samuel R Kaufman; Phyllis Yan; David C Miller; Florian R Schroeck; Ted A Skolarus; Vahakn B Shahinian; Brent K Hollenbeck
Journal:  J Urol       Date:  2016-07-15       Impact factor: 7.450

6.  Facilitating Clinical Outcomes Assessment through the automated identification of quality measures for prostate cancer surgery.

Authors:  Leonard W D'Avolio; Mark S Litwin; Selwyn O Rogers; Alex A T Bui
Journal:  J Am Med Inform Assoc       Date:  2008-02-28       Impact factor: 4.497

7.  Quality indicators of clinical cancer care for prostate cancer: a population-based study in southern Switzerland.

Authors:  Laura Ortelli; Alessandra Spitale; Luca Mazzucchelli; Andrea Bordoni
Journal:  BMC Cancer       Date:  2018-07-11       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.